09/12/2024
7:20 PM | Opaleye Management Inc. (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
6:11 PM | Opaleye Management Inc. (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2024
3:05 PM | Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Shefferman Jesse (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
3:16 PM | Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
07/18/2024
3:05 PM | Opaleye Management Inc. (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2024
6:56 PM | Opaleye Management Inc. (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
1:00 PM | Opaleye Management Inc. (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
06/28/2024
5:45 PM | Opaleye Management Inc. (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
5:00 PM | BESHAR LUKE M (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
5:00 PM | GARCEAU ROGER (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
5:00 PM | Huang Jane (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
5:00 PM | Levy Richard S (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
5:00 PM | Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
SARGEN GREGORY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
5:00 PM | Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Solomon Michael Edward (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
5:00 PM | Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Smith Cynthia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
5:00 PM | Flannelly Barry P (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
6:01 PM | Opaleye Management Inc. (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
6:48 PM | Opaleye Management Inc. (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
5:57 PM | Opaleye Management Inc. (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
11:15 PM | Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
| Form EFFECT | |
05/02/2024
3:16 PM | Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
05/02/2024
7:05 AM | Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2024
7:10 AM | Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/25/2024
7:43 PM | Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G | |
04/09/2024
9:43 AM | CVI Investments, Inc. (Filed by)
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
| Form SC 13G | |
04/05/2024
7:14 AM | Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2024
4:17 PM | Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
7:05 AM | Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
7:10 AM | Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2024
6:11 PM | ORBIMED ADVISORS LLC (Filed by)
Protara Therapeutics, Inc. (Subject)
Protara Therapeutics (Subject)
| Form SC 13G/A | |
01/23/2024
3:05 PM | Fry Hannah (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2024
3:05 PM | Fabbio Patrick (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2024
3:05 PM | Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Zummo Jacqueline (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2024
3:05 PM | Bandari Jathin (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2024
3:05 PM | Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Shefferman Jesse (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/12/2024
3:05 PM | Bandari Jathin (Reporting)
Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/12/2024
3:05 PM | Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Zummo Jacqueline (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/12/2024
3:05 PM | Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Shefferman Jesse (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
3:30 PM | Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Shefferman Jesse (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
3:35 PM | Protara Therapeutics, Inc. (Issuer)
Protara Therapeutics (Issuer)
Zummo Jacqueline (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2023
11:15 PM | Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
| Form EFFECT | |
Big News: How the Upcoming Rate Cut and Elon Musk’s AI Could Transform Your Investments (Ad) The Federal Reserve is almost certainly about to cut interest rates, and history tells us that stocks often rally after such moves. In fact, based on my calculations, in seven out of nine rate-cut cycles since 1981, stocks have surged, delivering an average of 36.3% returns over two years.
But that's not all...
This time, there's another massive trigger on the horizon – Elon Musk's groundbreaking AI technology. Click here to learn how you can take advantage of these two monumental shifts right now. |
11/03/2023
7:31 AM | Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
11/03/2023
7:10 AM | Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/03/2023
7:20 AM | Protara Therapeutics, Inc. (Filer)
Protara Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
